Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year Low - Here's Why

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price hit a new 52-week low on Tuesday . The company traded as low as $25.12 and last traded at $25.15, with a volume of 756654 shares traded. The stock had previously closed at $26.39.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and dropped their price objective for the company from $43.00 to $35.00 in a research note on Friday, February 28th. Guggenheim assumed coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. Mizuho decreased their price target on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a report on Tuesday, March 25th. StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Finally, TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $50.39.

Acadia Healthcare Price Performance

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business has a fifty day moving average of $31.39 and a 200-day moving average of $39.79. The firm has a market capitalization of $2.20 billion, a P/E ratio of 7.84, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently bought and sold shares of the stock. Wellington Management Group LLP boosted its holdings in shares of Acadia Healthcare by 0.7% in the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock valued at $465,283,000 after acquiring an additional 76,490 shares in the last quarter. FMR LLC boosted its stake in Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after purchasing an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Acadia Healthcare by 18.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after purchasing an additional 486,395 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after buying an additional 454,044 shares in the last quarter. Finally, Madison Avenue Partners LP bought a new position in Acadia Healthcare during the fourth quarter valued at about $76,339,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.